Collaborative Care & Future Vision

Collaborative Care & Future Vision

Endocrinology

This episode explores the next frontier of SGLT2 inhibitors — from pivotal trials like DAPA-HF, DELIVER, and DAPA-CKD to their expanding role beyond diabetes. Through a cross-specialty dialogue, the panel highlights how these agents are shaping modern chronic disease management, outperforming older therapies, and revealing new potential paving the way for a future of truly integrated, proactive care.